Breaking News Instant updates and real-time market news.

AMTD

TD Ameritrade

$51.12

0.32 (0.63%)

, SCHW

Charles Schwab

$48.95

0.22 (0.45%)

07:45
12/09/19
12/09
07:45
12/09/19
07:45

TD Ameritrade shares fairly valued after merger announcement, says Raymond James

Raymond James analyst Patrick O'Shaughnessy downgraded TD Ameritrade (AMTD) to Market Perform from Outperform. The analyst views the shares as fairly valued following the Charles Schwab (SCHW) merger announcement. In a research note to investors, the analyst says he believes likely accretion from merger synergies is largely reflected in Schwab's stock at this point and, given the all-stock deal terms, suggests limited upside to TD Ameritrade as well.

AMTD

TD Ameritrade

$51.12

0.32 (0.63%)

SCHW

Charles Schwab

$48.95

0.22 (0.45%)

AMTD TD Ameritrade
$51.12

0.32 (0.63%)

11/27/19
LEHM
11/27/19
UPGRADE
Target $53
LEHM
Equal Weight
TD Ameritrade upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Jeremy Campbell upgraded TD Ameritrade (AMTD) to Equal Weight from Underweight with a $53 price target following the company's merger agreement with Charles Schwab (SCHW).
11/27/19
LEHM
11/27/19
UPGRADE
Target $49
LEHM
Equal Weight
Charles Schwab upgraded to Equal Weight with $49 price target at Barclays
Barclays analyst Jeremy Campbell upgraded Charles Schwab (SCHW) to Equal Weight from Underweight with a price target of $49, up from $35. The analyst this morning also upgraded TD Ameritrade (AMTD) to Equal Weight from Underweight. Schwab's acquisition of Ameritrade unlocks an expected $1.8B-$2B of cost synergies, Campbell tells investors in a research note. Based on the "relatively in-line valuation to the current price," he upgrades both stocks to Equal Weight.
12/02/19
UBSW
12/02/19
UPGRADE
Target $50
UBSW
Neutral
Charles Schwab upgraded to Neutral from Sell at UBS
UBS analyst Brennan Hawken upgraded Charles Schwab (SCHW) to Neutral from Sell with a price target of $50, up from $35. The analyst says the new price target assumes a 20-times forward earnings multiple vs. 14-times prior, with the benefits of eliminating $1.9B of expenses related to the TD Ameritrade (AMTD) merger offsetting the "environmental pressure and 'cash sorting' that drove his prior caution. Hawken further notes that investors may see an "attractive entry point" in time, but he remains concerned with revenue dis-synergy at TD Ameritrade, where clients may seeks to avoid a risk related to service integration in its active trader platform and which may see E-Trade (ETFC) picking up market share as a result.
12/09/19
RAJA
12/09/19
DOWNGRADE
RAJA
Market Perform
TD Ameritrade downgraded to Market Perform from Outperform at Raymond James
Raymond James analyst Patrick O'Shaughnessy downgraded TD Ameritrade (AMTD) to Market Perform from Outperform. The analyst views the shares as fairly valued following the Charles Schwab (SCHW) merger announcement.
SCHW Charles Schwab
$48.95

0.22 (0.45%)

11/27/19
LEHM
11/27/19
UPGRADE
Target $49
LEHM
Equal Weight
Charles Schwab upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Jeremy Campbell upgraded Charles Schwab to Equal Weight from Underweight with a $49 price target.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$510.34

-3.065 (-0.60%)

07:29
01/21/20
01/21
07:29
01/21/20
07:29
Recommendations
Tesla analyst commentary  »

Tesla near-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 24

    Feb

  • 23

    Mar

  • 23

    Mar

ORGS

Orgenesis

$5.40

0.36 (7.14%)

07:28
01/21/20
01/21
07:28
01/21/20
07:28
Hot Stocks
Orgenesis announces $9.2M private placement »

Orgenesis announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAC

Lithium Americas

$4.12

-0.05 (-1.20%)

07:27
01/21/20
01/21
07:27
01/21/20
07:27
Hot Stocks
Lithium Americas receives notice of intent for Thacker Pass lithium project »

Lithium Americas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 12

    Mar

EQT

EQT Corporation

$8.25

-0.28 (-3.28%)

07:27
01/21/20
01/21
07:27
01/21/20
07:27
Upgrade
EQT Corporation rating change  »

EQT Corporation upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VERU

Veru

$4.19

0.07 (1.70%)

07:25
01/21/20
01/21
07:25
01/21/20
07:25
Recommendations
Veru analyst commentary  »

Veru price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUAN

Nuance

$19.74

-0.02 (-0.10%)

07:24
01/21/20
01/21
07:24
01/21/20
07:24
Hot Stocks
Nuance announces Dragon Medical One availability in France, Belgium, Netherlands »

Nuance Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 05

    Feb

MRSN

Mersana Therapeutics

$8.05

0.42 (5.50%)

07:23
01/21/20
01/21
07:23
01/21/20
07:23
Recommendations
Mersana Therapeutics analyst commentary  »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$85.35

-1.66 (-1.91%)

07:22
01/21/20
01/21
07:22
01/21/20
07:22
Upgrade
EOG Resources rating change  »

EOG Resources upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

KMDA

Kamada

$6.62

0.09 (1.38%)

07:21
01/21/20
01/21
07:21
01/21/20
07:21
Hot Stocks
Kamada announces $25M private placement with FIMI Opportunity Fund »

Kamada announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTHM

Livent

$8.90

0.05 (0.57%)

07:21
01/21/20
01/21
07:21
01/21/20
07:21
Downgrade
Livent rating change  »

Livent downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KVHI

KVH Industries

$10.91

0.05 (0.46%)

, LMT

Lockheed Martin

$425.62

-0.055 (-0.01%)

07:20
01/21/20
01/21
07:20
01/21/20
07:20
Hot Stocks
Lockheed Martin selects KVH fiber optic gyro for infrared search, track system »

KVH Industries (KVHI)…

KVHI

KVH Industries

$10.91

0.05 (0.46%)

LMT

Lockheed Martin

$425.62

-0.055 (-0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

BIDU

Baidu

$139.64

0.2 (0.14%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Recommendations
Baidu analyst commentary  »

Baidu price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

DIS

Disney

$144.25

-0.85 (-0.59%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Hot Stocks
Disney+ moves up EMEA launch date to March 24 »

Disney's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

RDHL

RedHill Biopharma

$6.16

0.11 (1.82%)

07:18
01/21/20
01/21
07:18
01/21/20
07:18
Hot Stocks
RedHill Biopharma discontinues promotion of Donnatal, EnteraGam »

RedHill Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$166.57

4.77 (2.95%)

07:17
01/21/20
01/21
07:17
01/21/20
07:17
Initiation
Kansas City Southern initiated  »

Benchmark starts Kansas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$170.73

2.85 (1.70%)

07:16
01/21/20
01/21
07:16
01/21/20
07:16
Hot Stocks
BeiGene says Phase 3 trial of tislelizumab meets primary endpoint »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CSX

CSX

$76.36

-0.39 (-0.51%)

07:16
01/21/20
01/21
07:16
01/21/20
07:16
Initiation
CSX initiated  »

Benchmark doesn't…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PDD

Pinduoduo

$39.43

-0.07 (-0.18%)

07:15
01/21/20
01/21
07:15
01/21/20
07:15
Recommendations
Pinduoduo analyst commentary  »

Pinduoduo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MA

MasterCard

$323.60

3.36 (1.05%)

07:15
01/21/20
01/21
07:15
01/21/20
07:15
Initiation
MasterCard initiated  »

MasterCard initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

V

Visa

$204.71

3.765 (1.87%)

07:14
01/21/20
01/21
07:14
01/21/20
07:14
Initiation
Visa initiated  »

Visa initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

  • 30

    Jan

  • 11

    Feb

ETON

Eton Pharmaceuticals

$7.14

-0.3 (-4.03%)

07:14
01/21/20
01/21
07:14
01/21/20
07:14
Hot Stocks
Eton Pharmaceuticals, Xellia announce Biorphen co-promotion agreement »

Eton Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Mar

MYGN

Myriad Genetics

$28.71

-0.21 (-0.73%)

, AZN

AstraZeneca

$51.34

0.84 (1.66%)

07:13
01/21/20
01/21
07:13
01/21/20
07:13
Hot Stocks
Myriad Genetics submits sPMA for BRACAnalysis CDx as companion diagnostic »

Myriad Genetics (MYGN)…

MYGN

Myriad Genetics

$28.71

-0.21 (-0.73%)

AZN

AstraZeneca

$51.34

0.84 (1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 06

    Feb

  • 13

    Feb

BABA

Alibaba

$227.41

3.53 (1.58%)

07:12
01/21/20
01/21
07:12
01/21/20
07:12
Recommendations
Alibaba analyst commentary  »

Alibaba price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 13

    Feb

SWTX

SpringsWorks Therapeutics

$35.77

0.07 (0.20%)

07:12
01/21/20
01/21
07:12
01/21/20
07:12
Recommendations
SpringsWorks Therapeutics analyst commentary  »

SpringsWorks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEGA

Pegasystems

$86.47

0.64 (0.75%)

07:12
01/21/20
01/21
07:12
01/21/20
07:12
Initiation
Pegasystems initiated  »

Pegasystems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 05

    Mar

  • 10

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.